Upload Avatar (500 x 500)
Xuanwen Bao
xuanwen.bao@zju.edu.cn
Chinese, English, German
Zhejiang
Zhejiang University
Medical
  • 2020 PhD: Technical University of Munich, School of Medicine
  • Zhejiang University 'Clinical Outstanding Young Talent' cultivation target
  • 2016.10-2020.07 - Helmholtz Zentrum München - Bioinformatics
  • 2014.08-2016.06 - Institute of Chemistry and Physics, Chinese Academy of Sciences - Microfluidic Systems Research
Exploring tumor spatial distribution heterogeneity based on deep learning and high-throughput omics
Regulating tumor immunotherapy by targeting tumor-associated macrophages
Computational Biology
Bioinformatics
  • A Pathologically Friendly Strategy for Determining the Organ-specific Spatial Tumor Microenvironment Topology in Lung Adenocarcinoma through the Integration of snRandom-seq and Imaging Mass Cytometry, XQ Sun+, X Teng+, C Liu+, ... Y Shi*, & XW Bao*, 2024
  • Pan-Cancer Single-Cell and Spatial-Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy, C Liu+, JD Xie+, B Lin+, ... XW Bao*, & Zhao P*, 2024
  • A multiomics analysis-assisted deep learning model identifies a macrophage-oriented module as a potential therapeutic target in colorectal cancer, XW Bao+*, Li Q+, Chen D+, et al., 2024
  • A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study, C Liu+, XF Cheng+, K Han+, ... XW Bao*, & Zhao P*, D Chen*, 2024
  • Induction of Tumor Ferroptosis-Dependent Immunity via an Injectable Attractive Pickering Emulsion Gel, Dai XM, J Zhang, XW Bao, et al., 2023
  • An immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis, Bao X, Wang DY, Dai XM, et al., 2023
  • Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multi-Omics Analysis, Bao X, Li Q, Chen J, et al., 2022
  • MS4A15 drives ferroptosis resistance through calcium-restricted lipid remodeling, Xin, S., Mueller, C., Pfeiffer, S., Kraft, V. A., Merl-Pham, J., Bao, X., ... & Schick, J. A., 2022
  • Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy, Bao X, Zhang H, Wu W, et al., 2020
  • Development and validation of a meta-learning-based multi-modal deep learning algorithm for detection of peritoneal metastasis, Zhang H, Zhu X, Li B, et al., 2022
  • Construction of TME and identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma, Liu, L., Zhang, R., Deng, J., Dai, X., Zhu, X., Fu, Q., ... & Bao, X., 2022
  • Enhanced radiotherapy efficacy and induced anti-tumor immunity in HCC by improving hypoxia microenvironment using oxygen microcapsules, Dai, X., Ruan, J., Guo, Y., Sun, Z., Liu, J., Bao, X., ... & Zhao, P., 2021
  • Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma, Chen, D., Bao, X., Zhang, R., Ding, Y., Zhang, M., Li, B., ... & Zhao, P., 2021
  • Characterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic Value, Bao, X., Wang, K., Liu, M., Li, B., Wang, H., Jin, K., ... & Xing, B., 2021
  • Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients, Shi, R., Bao, X., Unger, K., Sun, J., Lu, S., Manapov, F., ... & Li, M., 2021
  • Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC, Bao, X., Shi, R., Zhao, T., Wang, Y., Anastasov, N., Rosemann, M., & Fang, W., 2021
  • Nonsense-mediated decay factor SMG7 sensitizes cells to TNFα-induced apoptosis via CYLD tumor suppressor and the noncoding oncogene Pvt1, Yang, L., Kraft, V. A., Pfeiffer, S., Merl‐Pham, J., Bao, X., An, Y., ... & Schick, J. A., 2020
  • Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes, Shi R, Bao X, Sun J, et al., 2020
  • Extended in vitro culture of primary human mesenchymal stem cells downregulates Brca1‐related genes and impairs DNA double‐strand break recognition, Bao X, Wang J, Zhou G, et al., 2020
  • Establishment and validation of an individualized cell cycle process-related gene signature to predict cancer-specific survival in patients with bladder cancer, Shi R, Bao X, Rogowski P, et al., 2020
  • Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma, Bao X, Shi R, Zhao T, et al., 2020
  • GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling, Kraft V A N, Bezjian C T, Pfeiffer S, et al., 2019
  • A novel gene signature-based model predicts biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy, Shi R, Bao X, Weischenfeldt J, et al., 2019
  • Development of a membrane lipid metabolism–based signature to predict overall survival for personalized medicine in ccRCC patients, Bao M, Shi R, Zhang K, Bao X., 2019
  • Long-term culture of mesenchymal stem cells impairs ATM-dependent recognition of DNA breaks and increases genetic instability, Hladik, D., Höfig, I., Oestreicher, U., Beckers, J., Matjanovski, M., Bao, X., ... & Rosemann, M., 2019
  • A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis, Wang, Y., Zhang, Q., Gao, Z., Xin, S., Zhao, Y., Zhang, K., ... & Bao, X., 2019
  • A novel epigenetic signature for overall survival prediction in patients with breast cancer, Bao, X., Anastasov, N., Wang, Y., & Rosemann, M., 2019
Deep Learning High-Throughput Omics Tumor Spatial Distribution Tumor Heterogeneity Tumor-Associated Macrophages Immunotherapy Computational Biology Bioinformatics Cell Interaction Tumor Microenvironment

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.